Membrane to nuclear signalling - Lectures 25-35 (Christopher Pin) Flashcards
What’s needed for a rapid response (i.e. change) in gene expression due to an environmental stimulus?
- Something on the surface to recognize the environment change- receptors (ligands) or chemicals (ions, chemicals)
- Existing networks of proteins that can rapidly switch from an active to inactive state (or vice versa) - transmit signals, post translational modification
- Mechanism for entering the nucleus quickly and efficiently (signal into nucleus)
- Genes that are poised to be activated (or repressed) - transcription factors, ability to change the gene activity
Describe WNT signalling
- WNT signalling was first identified in 1982 in cancer biology; refers to Wingless and Int-1 (work in drosophila)
- Allows cross talk between cells (paracrine or autocrine signalling) or from one developmental structure to another
- There is canonical and three non-canonical pathways
- pathways trigger changes in gene expression in direct or indirect way
What are the different WNT signalling types?
- Canonical
- Non-canonical, Planar cell polarity
- Non-canonical, Wnt/calcium
- Non-canonical, Wnt5/Fzd2
- there are common parts to each pathway including:
WNT ligand (19 in total - some redundancy, not all diff outcomes, redundancy is important tho)
Frizzled receptor (FZD) for recognizing WNT
- Differential WNT expression, different FZD receptors and co-factors, and downstream mediators dictate WNT signalling outcomes
e.g. WNT5 activates non-canonical pathways
Describe the WNT canonical signalling
OFF state:
- maintained in inactive state, WNT binds repressor
- cell surface proteins bind to frizzled (FZD) and target it for degradation (by ubiquitination)
- Disheveled (DVL) is ubiquitinated and targeted for degradation
- B-catenin is bound by the B-catenin destruction complex (Axin, APC and GSK)
- B-catenin is phosphorylated and targeted for degradation by the proteasome (diff degradation method)
- TCF is bound to target genes but is not active
ON state:
- R-spondin (RSPO) binds to surface co-factor and prevents ubiquitination of FZD (RSPO is a cofactor for ligand, binds @ same time and helps get rid of repressor)
- WNT binds to FZD and triggers activation pathway
- Disheveled (DVL) is not ubiquitinated and binds to FZD
- active DVL de-activates the B-catenin destruction complex
- B-catenin translocates to the nucleus and binds T cell factors (TCF) to activate target genes
* Wnt signalling inhibits the B-catenin destruction complex, preventing its degradation and allowing translocation to the nucleus
- canonical WNT signalling is required for most developmental processes (really early embryonically affects - don’t get implantation)
- deletion of B-catenin of WNT3 causes early embryonic lethality but need the appropriate amount of WNT signalling
State the required parts of a response as from the WNT signalling
- Something on the surface to recognize the environment change: frizzled receptor recognizing WNT ligands (e.g. WNT3)
- Existing networks of protein that can rapidly switch from an active to inactive state: B-catenin stabilization and release from the destruction complex (disheveled)
- Mechanism for entering the nucleus quickly and efficiently: several mechanisms have been reported that involve interaction with other transcription factors, the nuclear pore complex and importins. We will discuss these in later lectures.
- Genes that are poised to be activated (or repressed): some target genes are maintained in a “poised” state by epigenetic modifications. B-catenin may also be able to displace repressive factors binding LEF1/TCF
What does deletion of inhibitor of WNT signalling tend to lead to?
Leads to loss of anterior neural development
Describe the WNT non-canonical planar cell polarity signalling
*sets polarity in development, outside vs inside the embryo
- something on the surface to recognize the environment change: frizzled receptor recognizing WNT ligands (WNT 11)
- existing networks of proteins that can rapidly switch from an active to inactive state: JUN (mitogen activated protein kinase; MAPK phosphorylation)
- mechanism for entering the nucleus quickly and efficiently: phosphorylation allows nuclear localization (JUN)
- genes that are poised to be activated (or repressed): JUN target genes are numerous and may already be expressed at low levels (AP1 activates thousands of genes)
Describe the WNT non-canonical WNT/calcium signalling
- something on the surface to recognize the environment change: frizzled receptor recognizing WNT ligands (WNT5)
- existing network of proteins that can rapidly switch from an active to inactive state: protein kinase C (PKC) activation
- mechanism for entering the nucleus: phosphorylation leads to activation of a nuclear transcription factor (PKC-NFAT)
- genes that are poised to be activated (or repressed: NFAT contributes to existing transcriptional complexes (transcription factor very receptive to calcium - can affect inflammatory process)
What does loss of WNT5 expression lead to? (non-canonical, wnt/calcium signalling)
- loss of WNT5 expression leads to truncated anterior to posterior axis (with incomplete outgrowth of distal limbs, genitals and tail) and shortening of limbs (skeletal defect)
- also causes impaired distal lung morphogenesis
- limited growth of limbs, cranial lack of development
- WNT5 is very important protein, not redundant, can’t get rid of and replace with something else
What does over-expression of WNT5 lead to?
- increase WNT5 expression leads to cranial facial defects, abnormal skull development
- also causes loss of hair follicles
Describe what happens when there are dominant B-catenin mutations
Is this WNT signalling?
- cause intellectual disability with recognizable syndromic features
- microcephaly, a full tip of the nose, and thin upper lip
- B-catenin was originally as a component in the adherens junction complex
- the membrane bound complex allows signalling and attachment to the cytoskeleton
- loss of function and gain of functions in B-catenin can have multiple affects including cell communication, signalling and gene expression
Describe WNTs in cancer
- stomach and intestinal epithelium is constantly turning over
- stem cells sit at the base of the glands (base of crypt)
- high levels of WNT signalling allow cells to proliferate and maintain an un-differentiated fate (stay undifferentiated at bottom, move up, less signalling, can now differentiate)
- as cells move up the gland, WNT signalling decreases
- growing cells in the presence of WNT and R-spondin allow the growth and maintenance of organoids (maintain them as stem cells, keep them proliferating - can grow in a specific way)
- rapid growth in culture and develops a single cell epithelium
- can replicate this from a single cell
(single cell grew in the presence of WNT ligand (triggers signalling) - proliferates forms cyst-like structure - recapitulating
What proteins/ molecules are associated with different cancers?
- WNT = osteosarcoma, gastric cancer
- LRP6 = osteosarcomas, liver, and breast cancer
- Axin = adrenal cancer, colorectal cancer and breast cancer
- APC = colorectal cancer (driver for colorectal cancer - certain you’ll develop cancer with this mutation)
- TCF/LEF = liver and colorectal cancer
- there are proposed inhibitors of pathways - clinical trials, trying to block cancer/diseases - therapies
Describe TGFB and its signalling
- transforming growth factor (TGF) is a cytokine, discovered due to its ability to induce proliferation and growth of cells in culture
- works in a paracrine or autocrine fashion (not endocrine, signals self or cells around it)
- the TGF-B superfamily consists of >30 structurrally related polypeptide growth factors including: TGF-Bs(1-3), activins (A,B), inhibins (A,B), bone morphogenetic proteins (BMPs 1-20), growth differentiation factors including myostatin, nodal, leftys (1,2) (left/right patterning), mullerian-inhibiting susbtance (MIS)
-functions to regulate embryonic development and cellular homeostasis, including regulation of proliferation, differentiation, apoptosis and extracellular matrix remodelling in a cell and context specific manner - is dysregulated in numerous cancers having both positive and negative effects of tumour progression
What are the steps in TGF-B signalling?
- TGF-B (ligand) binds TGF-B receptor II, which is a serine/threonine kinase receptors
- TGF-B receptor II forms a heterotrimeric complex with TGF-B receptor I; active TGF-B receptor II phosphorylates and activates TGF-B receptor I (phosphorylation leads to dimerization of the two receptors)
- SARA (SMAD anchor for receptor activation) recruits receptor (R)-Smads to the complex; R-Smads are phosphorylated by TGF-B receptor I
- Two activated R-Smads form a complex with the common Smad, Smad4 (then go to target genes)
- Smad4/R-Smad translocates to the nucleus and interacts with transcription factors, co-activators or co-repressors to modulate gene expression (gives variable responses)
What is the different between canonical and non-canonical TGFB signalling?
Canonical TGFB signalling involves SMAD translocation while non-canonical signalling can trigger other mediators such as MAPKs - p38, JNK and ERK (SMAD not involved in non-canonical)
- in various cancers, SMAD4 gets mutated so TGFB is switched to non-canonical pathway
What are the differences between bone morphogenetic protein vs TGFB signalling?
- TGF-B is synthesized and secreted as an inactive precursor protein (needs to be cleaved); BMPs are secreted in their active form (can immediately bind, don’t have control - many inhibitors)
- activation of TGF-B1 involves proteolytic cleavage; BMP is regulated by antagonists which bind BMPs and prevent interactions with their respective type I and type II receptors
- TGF-B signalling involves SMADs 2/3; BMPs involve SMADS 1/5/8 (common between both is binding of SMAD4, common factor)
- involved in different developmental processes
How is TGF signalling regulated?
- receptor
- ligands (prevent cleavage or can prevent binding)
- second messenger inhibition
- control/ prevent localization of SMAD4
- regulate co factors
What are the affects of TGFB?
TGFB signalling factors (ligands, inhibitors and receptors) are expressed throughout development in all tissues and are required for most developmental processes
TGFB can also repress proliferation (+activate)
Affects cell migration (some receptors block while others promote)
What are the single knockout of signalling doses (TGFB)?
- TGFB1-I- mice: embryonic lethal, excessive systemic inflammatory response, massive infiltration of macrophages and lymphocytes into the heart and lungs
- TGFB2-I_ mice: embryonic lethal, ventricular septum defects (VSD), myocardial thinning, and a double outlet right ventricle (DORV) - heart, have multiple defects in most organs
- see thickening of layers, doesn’t block proliferation (increased proliferation, lack of differentiation)
- septal defect- blood goes from one ventricle to another
- more cartilage, not allowing bone differentiation (significant problems with rib cage)
- TGFB 1 and 2 are not redundant (although in several same pathways, both are important - noggin (NOG)-/- : growth plates are enlarged and joint initiation is disrupted
- mice with no Noggin show altered skeletal development in limbs, ribs and head - important for the correct patterning of limb
- loss of assymetry (NOG)-/-
Describe mutations in TGFB found in humans
- most complete loss of function mutations are lethal early in development (germline, not somatic
e.g. Marfan syndrome (MS)
What is Marfan syndrome (MS)?
- autosomal dominant multisystem
- cardiac abnormalities, skeletal manifestations and vision problems
- linked to mutations in the fibrillin-1 gene
- fibrillin normally stabilizes late in its inactive state
- mutant fibrillin proteins in MS patients fail to do so, resulting in elevated levels of active TGF-B
- mutations were identified in 7GFBR1+TGFBR2 in patients with MS
- abraham lincoln is believed to of had MS
- affects the connective tissues in the body
- eye problems, long arms and fingers, abnormal chest, heart and lung problems
- short torso
signs and symptoms: - disproportionately long legs, arms, toes and fingers
- extremely tall and slender build
- long, narrow face
- high arched neck and crowded teeth
- indented or protruding sternum
- dislocated lenses of the eyes
- high pressure in the eye
- cystic changes in the lungs
- flexible joints
- flat feet
- curved spine
- abnormal heart sounds
What is Loeys-Dietz syndrome?
Autosomal dominant disorder with:
- aortic aneurysm syndrome
- cleft palate, and widespread vascular dilation
- high risk for aortic dissection or rupture
- skeletal abnormalities
- somatic mutations in TGFBR2 and TGFBR1 (happen early in development)
- increased TGF-B signalling in their aortic walls, suggesting that these mutations are either gain of function
Describe SMAD4
- critical to both TGFB and BMP signalling pathways
- germline mutations for SMAD4 linked to:
1. Juvenile polyposis: SMAD protein complex is not activated and not transported to the nucleus (predisposed to colon cancer)
2. Hereditary hemorrhagic telangiectasia syndrome: mutations exist in TGFB receptors
3. Myhre syndrome: abnormally stable SMAD4 protein that remains active (are translated, unable to get ride of it, unable to inactivate or inhibit